Inflammatory Cytokine-associated Depression

Overview

Journal Brain Res

Specialty Neurology

Date 2014 Jul 9

PMID 25003554

Citations 74

Authors

Francis E Lotrich

Affiliations

Soon will be listed here.

Abstract

Inflammatory cytokines can sometimes trigger depression in humans, are often associated with depression, and can elicit some behaviors in animals that are homologous to major depression. Moreover, these cytokines can affect monoaminergic and glutamatergic systems, supporting an overlapping pathoetiology with major depression. This suggests that there could be a specific major depression subtype, inflammatory cytokine-associated depression (ICAD), which may require different therapeutic approaches. However, most people do not develop depression, even when exposed to sustained elevations in inflammatory cytokines. Thus several vulnerabilities and sources of resilience to inflammation-associated depression have been identified. These range from genetic differences in neurotrophic and serotonergic systems to sleep quality and omega-3 fatty acid levels. Replicating these sources of resilience as treatments could be one approach for preventing "ICAD". This article is part of a Special Issue entitled SI: Neuroimmunology in Health And Disease.

Citing Articles

Dopamine D1 receptor agonist alleviates post-weaning isolation-induced neuroinflammation and depression-like behaviors in female mice.

Zhao Z, Wang Y, Chen P, Tzeng S, Chen P, Kuo Y Behav Brain Funct. 2025; 21(1):6.

PMID: 40065395 PMC: 11895232. DOI: 10.1186/s12993-025-00269-y.

Antidepressant Activity of Agarwood Essential Oil: A Mechanistic Study on Inflammatory and Neuroprotective Signaling Pathways.

Zhang S, Chen X, Wang C, Sun Y, Gong B, Li D Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006068 PMC: 11859912. DOI: 10.3390/ph18020255.

The Anti-Inflammatory Potential of Tricyclic Antidepressants (TCAs): A Novel Therapeutic Approach to Atherosclerosis Pathophysiology.

Eslami M, Monemi M, Nazari M, Azami M, Shariat Rad P, Oksenych V Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006011 PMC: 11858810. DOI: 10.3390/ph18020197.

Assessment of IL-8, RANTES, MIG, MCP-1, IP-10, and IL-12p70 and Their Association with Anxiety and Quality of Life in Patients with Chronic Kidney Disease or After Kidney Transplantation.

Furtak G, Lerch N, Kozlowski M, Tkacz P, Piekara E, Lagodka M Int J Mol Sci. 2025; 25(24.

PMID: 39769214 PMC: 11676508. DOI: 10.3390/ijms252413449.

Omega-3 Fatty Acids and Neuroinflammation in Depression: Targeting Damage-Associated Molecular Patterns and Neural Biomarkers.

Malau I, Chang J, Lin Y, Chang C, Chiu W, Su K Cells. 2024; 13(21.

PMID: 39513898 PMC: 11544853. DOI: 10.3390/cells13211791.

References

Raison C, Miller A . Malaise, melancholia and madness: the evolutionary legacy of an inflammatory bias. Brain Behav Immun. 2013; 31:1-8. PMC: 3678371. DOI: 10.1016/j.bbi.2013.04.009. View

Kihlstrom J, Cantor Kihlstrom L . Somatization as illness behavior. Adv Mind Body Med. 2002; 17(4):240-3; discussion 270-6. View

McNamara R, Jandacek R, Rider T, Tso P, Cole-Strauss A, Lipton J . Omega-3 fatty acid deficiency increases constitutive pro-inflammatory cytokine production in rats: relationship with central serotonin turnover. Prostaglandins Leukot Essent Fatty Acids. 2010; 83(4-6):185-91. PMC: 2993848. DOI: 10.1016/j.plefa.2010.08.004. View

Stone T . Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection. Trends Pharmacol Sci. 2000; 21(4):149-54. DOI: 10.1016/s0165-6147(00)01451-6. View

Romcy-Pereira R, Leite J, Garcia-Cairasco N . Synaptic plasticity along the sleep-wake cycle: implications for epilepsy. Epilepsy Behav. 2008; 14 Suppl 1:47-53. DOI: 10.1016/j.yebeh.2008.09.026. View

Bennett B, Hickie I, Quigley B, Brennan C, Wakefield D, Douglas M . The relationship between fatigue, psychological and immunological variables in acute infectious illness. Aust N Z J Psychiatry. 1998; 32(2):180-6. DOI: 10.3109/00048679809062727. View

Sukoff Rizzo S, Neal S, Hughes Z, Beyna M, Rosenzweig-Lipson S, Moss S . Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes. Transl Psychiatry. 2012; 2:e199. PMC: 3565187. DOI: 10.1038/tp.2012.120. View

Su K, Lai H, Yang H, Su W, Peng C, Chang J . Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial. Biol Psychiatry. 2014; 76(7):559-66. DOI: 10.1016/j.biopsych.2014.01.008. View

Ida T, Hara M, Nakamura Y, Kozaki S, Tsunoda S, Ihara H . Cytokine-induced enhancement of calcium-dependent glutamate release from astrocytes mediated by nitric oxide. Neurosci Lett. 2008; 432(3):232-6. DOI: 10.1016/j.neulet.2007.12.047. View

10.

Pan Y, Lin W, Wang W, Qi X, Wang D, Tang M . The effects of central pro-and anti-inflammatory immune challenges on depressive-like behavior induced by chronic forced swim stress in rats. Behav Brain Res. 2013; 247:232-40. DOI: 10.1016/j.bbr.2013.03.031. View

11.

Fahey B, Hickey B, Kelleher D, ODwyer A, OMara S . The widely-used anti-viral drug interferon-alpha induces depressive- and anxiogenic-like effects in healthy rats. Behav Brain Res. 2007; 182(1):80-7. DOI: 10.1016/j.bbr.2007.05.005. View

12.

Song C, Merali Z, Anisman H . Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2 or interleukin-6 treatment. Neuroscience. 1999; 88(3):823-36. DOI: 10.1016/s0306-4522(98)00271-1. View

13.

Raison C, Rutherford R, Woolwine B, Shuo C, Schettler P, Drake D . A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry. 2012; 70(1):31-41. PMC: 4015348. DOI: 10.1001/2013.jamapsychiatry.4. View

14.

Irwin M, Miller C . Decreased natural killer cell responses and altered interleukin-6 and interleukin-10 production in alcoholism: an interaction between alcohol dependence and African-American ethnicity. Alcohol Clin Exp Res. 2000; 24(4):560-9. View

15.

Prather A, Rabinovitz M, Pollock B, Lotrich F . Cytokine-induced depression during IFN-alpha treatment: the role of IL-6 and sleep quality. Brain Behav Immun. 2009; 23(8):1109-16. PMC: 2783448. DOI: 10.1016/j.bbi.2009.07.001. View

16.

Kim J, Stewart R, Kim S, Kim S, Bae K, Kang H . Physical health and incident late-life depression: modification by cytokine genes. Neurobiol Aging. 2012; 34(1):356.e1-9. DOI: 10.1016/j.neurobiolaging.2012.01.111. View

17.

Lotrich F, Rabinovitz M, Gironda P, Pollock B . Depression following pegylated interferon-alpha: characteristics and vulnerability. J Psychosom Res. 2007; 63(2):131-5. PMC: 2104514. DOI: 10.1016/j.jpsychores.2007.05.013. View

18.

Kazumori H, Ishihara S, Rumi M, Ortega-Cava C, Kadowaki Y, Kinoshita Y . Transforming growth factor-alpha directly augments histidine decarboxylase and vesicular monoamine transporter 2 production in rat enterochromaffin-like cells. Am J Physiol Gastrointest Liver Physiol. 2003; 286(3):G508-14. DOI: 10.1152/ajpgi.00269.2003. View

19.

Danese A, Moffitt T, Pariante C, Ambler A, Poulton R, Caspi A . Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Arch Gen Psychiatry. 2008; 65(4):409-15. PMC: 2923056. DOI: 10.1001/archpsyc.65.4.409. View

20.

Felger J, Miller A . Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise. Front Neuroendocrinol. 2012; 33(3):315-27. PMC: 3484236. DOI: 10.1016/j.yfrne.2012.09.003. View